|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Stephan HerzigPublisher: Springer International Publishing AG Imprint: Springer International Publishing AG Edition: Softcover reprint of the original 1st ed. 2016 Volume: 233 Weight: 8.071kg ISBN: 9783319806570ISBN 10: 3319806572 Pages: 469 Publication Date: 20 April 2018 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of Contents1 Central nervous system control of metabolism.- 2 Glucocorticoids and metabolic control.- 3 Anti-lipidemic drugs.- 4 Genomics and metabolism.- 5 cAMP signaling.- 6 cGMP and brown adipose tissue.- 7 Inflammatory signaling and metabolism.- 8 Insulin signaling.- 9 Nuclear receptor co-factors in metabolism.- 10 Novel treatment options in diabetes.- 11 Adipose tissue stem cells.- 12 Adipokines.- 13 Immune cells and metabolism.- 14 Brown adipose tissue in humans.- 15 Diabetes and Cancer.- 16 Cancer Cell Metabolism.- 17 Incretins.ReviewsAuthor InformationStephan Herzig obtained his PhD from the University of Göttingen, Germany, in 1999. Supported by the German Research Foundation DFG he then joined the Salk Institute for Biological Studies, La Jolla, CA, for his postdoctoral training. In 2004, he established an Emmy-Noether and Marie Curie Junior Research Group at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. He became Head of a Joint Research Division between the DKFZ, Heidelberg University, and Heidelberg University Hospital in 2010, followed by his appointment as a Full W3 Professor at the Medical Faculty of Heidelberg University. Since 2015, Stephan Herzig is the director of the Institute for Diabetesand Cancer (IDC) at the Helmholtz Center Munich and he holds the chair in Molecular Metabolic Control at the Technical University Munich as well as a Honorary Professorship at the Medical Faculty at Heidelberg University. Stephan Herzig studies the molecular mechanisms of severe metabolic disorders and their complications, including insulin resistance, type 2 diabetes, and cancer. Tab Content 6Author Website:Countries AvailableAll regions |